Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Cannabix Technologies Inc.

BLOZFPNK
Healthcare
Medical - Devices
$0.43
$0.00(0.00%)
U.S. Market opens in 14h 46m

Cannabix Technologies Inc. Fundamental Analysis

Cannabix Technologies Inc. (BLOZF) shows weak financial fundamentals with a PE ratio of -11.19, profit margin of -51.42%, and ROE of -2.60%. The company generates $0.0B in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Current Ratio6.42

Areas of Concern

ROE-2.60%
Operating Margin-50.54%
Cash Position3.08%
We analyze BLOZF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -4086.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-4086.8/100

We analyze BLOZF's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLOZF struggles to generate sufficient returns from assets.

ROA > 10%
-2.91%

Valuation Score

Excellent

BLOZF trades at attractive valuation levels.

PE < 25
-11.19
PEG Ratio < 2
1.30

Growth Score

Weak

BLOZF faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-46.52%

Financial Health Score

Excellent

BLOZF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
6.42

Profitability Score

Weak

BLOZF struggles to sustain strong margins.

ROE > 15%
-259.72%
Net Margin ≥ 15%
-51.42%
Positive Free Cash Flow
No

Key Financial Metrics

Is BLOZF Expensive or Cheap?

P/E Ratio

BLOZF trades at -11.19 times earnings. This suggests potential undervaluation.

-11.19

PEG Ratio

When adjusting for growth, BLOZF's PEG of 1.30 indicates fair valuation.

1.30

Price to Book

The market values Cannabix Technologies Inc. at 37.86 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

37.86

EV/EBITDA

Enterprise value stands at -11.66 times EBITDA. This is generally considered low.

-11.66

How Well Does BLOZF Make Money?

Net Profit Margin

For every $100 in sales, Cannabix Technologies Inc. keeps $-51.42 as profit after all expenses.

-51.42%

Operating Margin

Core operations generate -50.54 in profit for every $100 in revenue, before interest and taxes.

-50.54%

ROE

Management delivers $-2.60 in profit for every $100 of shareholder equity.

-2.60%

ROA

Cannabix Technologies Inc. generates $-2.91 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.91%

Following the Money - Real Cash Generation

Operating Cash Flow

Cannabix Technologies Inc. generates limited operating cash flow of $-2.04M, signaling weaker underlying cash strength.

$-2.04M

Free Cash Flow

Cannabix Technologies Inc. generates weak or negative free cash flow of $-2.05M, restricting financial flexibility.

$-2.05M

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

BLOZF converts -2.88% of its market value into free cash.

-2.88%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-11.19

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.30

vs 25 benchmark

P/B Ratio

Price to book value ratio

37.86

vs 25 benchmark

P/S Ratio

Price to sales ratio

575.21

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.42

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.60

vs 25 benchmark

ROA

Return on assets percentage

-2.91

vs 25 benchmark

ROCE

Return on capital employed

-3.33

vs 25 benchmark

How BLOZF Stacks Against Its Sector Peers

MetricBLOZF ValueSector AveragePerformance
P/E Ratio-11.1929.45 Better (Cheaper)
ROE-259.72%779.00% Weak
Net Margin-5142.08%-24930.00% (disorted) Weak
Debt/Equity0.050.26 Strong (Low Leverage)
Current Ratio6.424.65 Strong Liquidity
ROA-290.97%-19333.00% (disorted) Weak

BLOZF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cannabix Technologies Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

28.02%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-1.72%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ